These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3930530)

  • 21. Unexpected inhibition of cholesterol 7 alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits.
    Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Parker TS; Chen TS; Zhao Z; Donnelly TM; Tint GS
    J Clin Invest; 1995 Apr; 95(4):1497-504. PubMed ID: 7706454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Formation of mevalonic acid, sterols and bile acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in the liver of rabbits with experimental hypercholesterolemia].
    Klimov AN; Poliakova ED; Vasil'eva LE; Denisenko TV; Dizhe EB
    Biokhimiia; 1987 Feb; 52(2):239-46. PubMed ID: 2882784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of high levels of selected dietary essential amino acids on hypercholesterolemia and down-regulation of hepatic LDL receptors in rabbits.
    Kurowska EM; Carroll KK
    Biochim Biophys Acta; 1992 Jun; 1126(2):185-91. PubMed ID: 1627621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cholesterol metabolism in the liver in vivo and in vitro.
    Cohen LH; Princen HM; Kwekkeboom J; Havekes LM; Kempen HJ
    Biochem Soc Trans; 1987 Jun; 15(3):339-40. PubMed ID: 3040491
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.
    Huff MW; Telford DE; Edwards JY; Burnett JR; Barrett PH; Rapp SR; Napawan N; Keller BT
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1884-91. PubMed ID: 12426220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new type of familial hypercholesterolaemia.
    Higgins MJ; Lecamwasam DS; Galton DJ
    Lancet; 1975 Oct; 2(7938):737-40. PubMed ID: 52771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into cholesterol dynamics.
    Miettinen TA
    Arch Surg; 1978 Jan; 113(1):45-9. PubMed ID: 202222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipoproteins: recent developments.
    Gotto AM; Jackson RL
    Adv Exp Med Biol; 1977; 82():15-33. PubMed ID: 200086
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
    J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1994 Mack-Forster Award Lecture. Review. Studies on the regulation of hepatic cholesterol metabolism in humans.
    Angelin B
    Eur J Clin Invest; 1995 Apr; 25(4):215-24. PubMed ID: 7601197
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative feedback loop of cholesterol regulation is impaired in the livers of patients with Alagille syndrome.
    Miyahara Y; Bessho K; Kondou H; Hasegawa Y; Yasuda K; Ida S; Ihara Y; Mizuta K; Miyoshi Y; Ozono K
    Clin Chim Acta; 2015 Feb; 440():49-54. PubMed ID: 25444747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human anencephalic adrenal tissue: low density lipoprotein metabolism and cholesterol synthesis.
    Carr BR; Ohashi M; MacDonald PC; Simpson ER
    J Clin Endocrinol Metab; 1981 Aug; 53(2):406-11. PubMed ID: 6265491
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of casein-induced hypercholesterolemia: primary and secondary features.
    Beynen AC; Van der Meer R; West CE
    Atherosclerosis; 1986 Jun; 60(3):291-3. PubMed ID: 3730049
    [No Abstract]   [Full Text] [Related]  

  • 36. Up-regulation of low density lipoprotein receptor by a novel isobenzofranone derivative, MD-700.
    Murakami S; Nitanai I; Uchida S; Kondo-Ohta Y; Asami Y; Kondo K; Sato M; Kawashima A; Hara H; Tomisawa K; Mei HB; Xiang CZ
    Atherosclerosis; 1999 Oct; 146(2):281-90. PubMed ID: 10532684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Needed: new therapy for hypercholesterolemia.
    Bilheimer DW
    N Engl J Med; 1977 Mar; 296(9):508-10. PubMed ID: 189193
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical controls of liver cholesterol biosynthesis.
    Ott DB; Lachance PA
    Am J Clin Nutr; 1981 Oct; 34(10):2295-306. PubMed ID: 6170219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vivo evaluation in man of the transfer of esterified cholesterol between lipoproteins and into the liver and bile.
    Schwartz CC; Vlahcevic ZR; Halloran LG; Swell L
    Biochim Biophys Acta; 1981 Jan; 663(1):143-62. PubMed ID: 7011409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regulation of cholesterol synthesis, as focused on the regulation of HMG-CoA reductase (author's transl)].
    Endo A
    Seikagaku; 1980 Oct; 52(10):1033-49. PubMed ID: 7017025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.